Latest Conference Articles

Pembrolizumab Plus Lenvatinib Demonstrates Improved Overall Survival in Treatment of Advanced Endometrial Cancer

Pembrolizumab Plus Lenvatinib Demonstrates Improved Overall Survival in Treatment of Advanced Endometrial Cancer

March 24th 2021, 6:00pm

Society of Gynecologic Oncology Annual Meeting on Women’s Cancer

Results from the phase 3 KEYNOTE-775/study 309 trial found that Keytruda plus Lenvima reduced risk of death by 38%, with a median overall survival of 18.3 months

Study Finds Risk of Death Due to COVID-19 Not Raised by Recent Chemotherapy, Immunotherapy for Gynecologic Cancer

Study Finds Risk of Death Due to COVID-19 Not Raised by Recent Chemotherapy, Immunotherapy for Gynecologic Cancer

March 23rd 2021, 4:02pm

Society of Gynecologic Oncology Annual Meeting on Women’s Cancer

When analyzing the odds of death or hospitalization due to COVID-19, the researchers found that use of cytotoxic chemotherapy did not predict increased risk for either.

Study Demonstrates Promising Results for GEN-1 in Advanced Ovarian Cancer

Study Demonstrates Promising Results for GEN-1 in Advanced Ovarian Cancer

March 23rd 2021, 3:30pm

Society of Gynecologic Oncology Annual Meeting on Women’s Cancer

The company received Fast Track designation from the FDA for GEN-1, a DNA-mediated interleukin-12 (IL-12) immunotherapy.

Hormonal IUD Shows Promise as an Effective Treatment for Early Endometrial Cancer or Precancer

Hormonal IUD Shows Promise as an Effective Treatment for Early Endometrial Cancer or Precancer

March 22nd 2021, 12:45pm

Society of Gynecologic Oncology Annual Meeting on Women’s Cancer

According to study results presented at the SGO meeting, biopsies showed no signs of cancer or precancer in two-thirds of 165 women with stage I endometrial cancer or atypical endometrial hyperplasia, 6 months after insertion of the hormonal IUD.

Counseling Patients on Proper Use of CBD Products

Counseling Patients on Proper Use of CBD Products

March 17th 2021, 9:00pm

APhA

With a wide array of cannabidiol (CBD) and CBD extract products available without a prescription, pharmacists have an increasingly important role to play in counseling patients on which products may work for them and how they should be properly used.

Marialice S. Bennett Awarded Remington Honor Medal, APhA’s Highest Honor

Marialice S. Bennett Awarded Remington Honor Medal, APhA’s Highest Honor

March 17th 2021, 5:00pm

APhA

Bennett is the seventh woman to be recognized for the award since its inception in 1919.

Study Links Promotional Challenges to Patient Use of HIV Screenings in Pharmacies

Study Links Promotional Challenges to Patient Use of HIV Screenings in Pharmacies

March 17th 2021, 12:45pm

APhA

Results presented at the 2021 APhA Annual Meeting and Exposition cite advertising and marketing difficulties as main barrier to success of point-of-care service.

APhA Welcomes New President With a Focus on Providing Care to Communities

APhA Welcomes New President With a Focus on Providing Care to Communities

March 16th 2021, 11:45am

APhA

As a first-generation college graduate with a focus on providing care to underserved and low-income communities, new APhA President Sandra Leal said her main goal is to continue advocating for the pharmacy field.

Personalizing Breast Cancer Neoadjuvant and Adjuvant HER2-Targeted Therapy

Personalizing Breast Cancer Neoadjuvant and Adjuvant HER2-Targeted Therapy

March 11th 2021, 5:15pm

Miami Breast Cancer Conference

Debu Tripathy, MD, University of Texas, MD Anderson Cancer Center at Houston, discussed the basic requirements of personalizing therapy.

Study Examines Use of Neoadjuvant Chemotherapy in Elderly Patients With Breast Cancer

Study Examines Use of Neoadjuvant Chemotherapy in Elderly Patients With Breast Cancer

March 9th 2021, 1:30pm

Miami Breast Cancer Conference

The investigators performed a retrospective review of 215 patients age 65 years and older with TNBC or HER2+ breast cancer who underwent mastectomy from 2005 to 2020 at a single institution.